Emergent BioSolutions (EBS) is up 9.7%, or 54c to $6.03.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EBS:
- Emergent Biosolutions: Strong Operational Efficiency and Strategic Advancements Justify Buy Rating
- Emergent BioSolutions: Strong Q1 Performance and Strategic Growth Drive Buy Rating
- Emergent BioSolutions’ Earnings Call: A Balanced Outlook
- Emergent BioSolutions rises 29.3%
- Emergent BioSolutions rises 22.4%